$100 Invested In This Stock 20 Years Ago Would Be Worth $15,000 Today

Regeneron Pharmaceuticals REGN has outperformed the market over the past 20 years by 20.26% on an annualized basis producing an average annual return of 28.47%. Currently, Regeneron Pharmaceuticals has a market capitalization of $120.79 billion.

Buying $100 In REGN: If an investor had bought $100 of REGN stock 20 years ago, it would be worth $14,648.53 today based on a price of $1095.71 for REGN at the time of writing.

Regeneron Pharmaceuticals's Performance Over Last 20 Years

comp_fig

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsTrading IdeasBZI-POD
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!